Viatronix releases V3D-Cardiac

Advanced visualization firm Viatronix has received U.S. Food and Drug Administration (FDA) 510(k) approval for its V3D-Cardiac module.

V3D-Cardiac combines left ventricle and coronary analysis functions into a single module, according to the Stony Brook, NY-based firm.

Related Reading

Visage, Viatronix ink marketing deal, November 25, 2008

Road to RSNA, CAD, Viatronix, November 1, 2007

Viatronix joins forces with Canadian integrator, August 28, 2007

Viatronix, Medicsight net CE Mark, June 13, 2007

Viatronix completes Massachusetts installations, March 1, 2007

Copyright © 2008 AuntMinnie.com

Page 1 of 384
Next Page